Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE Trial: Renoprotective Pharmacotherapy in Children With Chronic Renal Failure
NCT00221845Phase 3Completed
- Sponsor
- Heidelberg University
- Start
- Jan 1998
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of ramipril, telmisartan in chronic kidney disease (CKD), sponsored by Heidelberg University. Started Jan 1998; status: completed.
02
Drugs
ramipriltelmisartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00221845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221845.